Status:
RECRUITING
Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
Lead Sponsor:
Tanta University
Conditions:
Glue Embolization
Pelvic Congestion Syndrome
Eligibility:
FEMALE
30-50 years
Phase:
NA
Brief Summary
The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.
Detailed Description
Pelvic congestion syndrome (PCS) is a common cause of chronic lower abdominal/pelvic pain, estimated to affect about 40 % of women, predominantly between the ages of 30 and 45.The treatment of PCS dep...
Eligibility Criteria
Inclusion
- Women aged from 30 to 50 years.
- Complaining from pelvic congestion syndrome.
Exclusion
- Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
- Patients who are treated with opiates to reduce pelvic pain in the period before the study.
- Patient with history of contrast allergy
- Patient with renal impairment
- Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst
- Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.
Key Trial Info
Start Date :
August 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06560294
Start Date
August 17 2024
End Date
October 1 2025
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, ElGharbia, Egypt, 31527